MAPT and early-onset autosomal dominant Alzheimer disease: GSK-3β has been reported to be involved in the pathogenesis of Alzheimer’s disease (AD) by phosphorylating tau protein to develop into paired helical filaments, leading to AD patients’ degenerative neuritis (45).